Constitutive activation of glycogen synthase kinase-3β correlates with better prognosis and cyclin-dependent kinase inhibitors in human gastric cancer

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Cho, Yu J ^a   Kim, Ji H ^b   Yoon, Jiyeon ^a   Cho, Sung J ^a   Ko, Young S ^a   Park, Jong Wan ^a   Lee, Hye S ^c   Lee, Hee E ^a   Kim, Woo H ^a   Lee, Byung L ^a  

^a Seoul National University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; CD82 ANTIGEN; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53; SMAD4 PROTEIN; TYROSINE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CELL; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CELL CULTURE; CELL CYCLE REGULATION; CHILD; DISTANT METASTASIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFANT; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; CELL CYCLE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PATHOLOGY; STOMACH TUMOR; TUMOR CELL CULTURE; TUMOR CELL LINE;

CELL CYCLE; CELL LINE, TUMOR; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LITHIUM CHLORIDE; PROGNOSIS; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 77955409200     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-91     Document Type: Article

References (33)

1. Saegusa M, Hashimura M, Kuwata T, Hamano M, Okayasu I. Crosstalk between NF-κB/p65 and β-catenin/TCF4/p300 signalling pathways through alterations in GSK-3β expression during trans-differentiation of endometrial carcinoma cells. J Pathol 2007, 213(1):35-45. 10.1002/path.2198, 17607667.
2. Wu LY, Semenya KA, Hardy RE, Hargreaves MK, Robinson SB, Pederson L, Sung JF, Haynes MA. Cancer rate differentials between blacks and whites in three metropolitan areas: a 10-year comparison. J Natl Med Assoc 1998, 90(7):410-416. 2608358, 9685776.
3. Endoh Y, Sakata K, Tamura G, Ohmura K, Ajioka Y, Watanabe H, Motoyama T. Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J Pathol 2000, 191(3):257-263. 10.1002/1096-9896(2000)9999:9999<::AID-PATH631>3.0.CO;2-2, 10878546.
4. Forde JE, Dale TC. Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol Life Sci 2007, 64(15):1930-1944. 10.1007/s00018-007-7045-7, 17530463.
5. Woodgett JR, Cohen P. Multisite phosphorylation of glycogen synthase. Molecular basis for the substrate specificity of glycogen synthase kinase-3 and casein kinase-II (glycogen synthase kinase-5). Biochim Biophys Acta 1984, 788(3):339-347.
6. Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003, 116(Pt 7):1175-1186. 10.1242/jcs.00384, 12615961.
7. Ghosh JC, Altieri DC. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3β in colorectal cancer cells. Clin Cancer Res 2005, 11(12):4580-4588. 10.1158/1078-0432.CCR-04-2624, 15958644.
8. Tan J, Zhuang L, Leong HS, Iyer NG, Liu ET, Yu Q. Pharmacologic modulation of glycogen synthase kinase-3β promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells. Cancer Res 2005, 65(19):9012-9020. 10.1158/0008-5472.CAN-05-1226, 16204075.
9. Shakoori A, Ougolkov A, Yu ZW, Zhang B, Modarressi MH, Billadeau DD, Mai M, Takahashi Y, Minamoto T. Deregulated GSK3β activity in colorectal cancer: its association with tumor cell survival and proliferation. Biochem Biophys Res Commun 2005, 334(4):1365-1373. 10.1016/j.bbrc.2005.07.041, 16043125.
10. Shakoori A, Mai W, Miyashita K, Yasumoto K, Takahashi Y, Ooi A, Kawakami K, Minamoto T. Inhibition of GSK-3β activity attenuates proliferation of human colon cancer cells in rodents. Cancer Sci 2007, 98(9):1388-1393. 10.1111/j.1349-7006.2007.00545.x, 17640304.
11. Cao Q, Lu X, Feng YJ. Glycogen synthase kinase-3β positively regulates the proliferation of human ovarian cancer cells. Cell Res 2006, 16(7):671-677. 10.1038/sj.cr.7310078, 16788573.
12. Kunnimalaiyaan M, Vaccaro AM, Ndiaye MA, Chen H. Inactivation of glycogen synthase kinase-3β, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells. Mol Cancer Ther 2007, 6(3):1151-1158. 10.1158/1535-7163.MCT-06-0665, 17363508.
13. Farago M, Dominguez I, Landesman-Bollag E, Xu X, Rosner A, Cardiff RD, Seldin DC. Kinase-inactive glycogen synthase kinase 3β promotes Wnt signaling and mammary tumorigenesis. Cancer Res 2005, 65(13):5792-5801. 10.1158/0008-5472.CAN-05-1021, 15994955.
14. Li Y, Wang Z, Kong D, Murthy S, Dou QP, Sheng S, Reddy GP, Sarkar FH. Regulation of FOXO3a/β-catenin/GSK-3β signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. J Biol Chem 2007, 282(29):21542-21550. 10.1074/jbc.M701978200, 17522055.
15. Wang Q, Zhou Y, Wang X, Evers BM. p27 Kip1 nuclear localization and cyclin-dependent kinase inhibitory activity are regulated by glycogen synthase kinase-3 in human colon cancer cells. Cell Death Differ 2008, 15(5):908-919. 10.1038/cdd.2008.2, 2432084, 18408738.
16. Liao X, Zhang L, Thrasher JB, Du J, Li B. Glycogen synthase kinase-3β suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer. Mol Cancer Ther 2003, 2(11):1215-1222.
17. Soto-Cerrato V, Vinals F, Lambert JR, Kelly JA, Perez-Tomas R. Prodigiosin induces the proapoptotic gene NAG-1 via glycogen synthase kinase-3β activity in human breast cancer cells. Mol Cancer Ther 2007, 6(1):362-369. 10.1158/1535-7163.MCT-06-0266, 17237295.
18. Ma C, Wang J, Gao Y, Gao TW, Chen G, Bower KA, Odetallah M, Ding M, Ke Z, Luo J. The role of glycogen synthase kinase 3β in the transformation of epidermal cells. Cancer Res 2007, 67(16):7756-7764. 10.1158/0008-5472.CAN-06-4665, 17699780.
19. Goto H, Kawano K, Kobayashi I, Sakai H, Yanagisawa S. Expression of cyclin D1 and GSK-3β and their predictive value of prognosis in squamous cell carcinomas of the tongue. Oral Oncol 2002, 38(6):549-556. 10.1016/S1368-8375(01)00121-X, 12167432.
20. Ding Q, He X, Xia W, Hsu JM, Chen CT, Li LY, Lee DF, Yang JY, Xie X, Liu JC, Hung MC. Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3β activity and associates with poor prognosis in human breast cancer. Cancer Res 2007, 67(10):4564-4571. 10.1158/0008-5472.CAN-06-1788, 17495324.
21. Zheng H, Saito H, Masuda S, Yang X, Takano Y. Phosphorylated GSK3β-ser9 and EGFR are good prognostic factors for lung carcinomas. Anticancer Res 2007, 27(5B):3561-3569.
22. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006, 12(3):354-362.
23. Mai W, Miyashita K, Shakoori A, Zhang B, Yu ZW, Takahashi Y, Motoo Y, Kawakami K, Minamoto T. Detection of active fraction of glycogen synthase kinase 3β in cancer cells by nonradioisotopic in vitro kinase assay. Oncology 2006, 71(3-4):297-305. 10.1159/000106429, 17652946.
24. Dar AA, Belkhiri A, El-Rifai W. The aurora kinase A regulates GSK-3β in gastric cancer cells. Oncogene 2009, 28(6):866-875. 10.1038/onc.2008.434, 2642527, 19060929.
25. Hirakawa H, Nakayama T, Shibata K, Sekine I. Association of cellular localization of glycogen synthase kinase 3β in the digestive tract with cancer development. Oncol Rep 2009, 22(3):481-485. 10.3892/or_00000460, 19639192.
26. Lee HS, Lee HK, Kim HS, Yang HK, Kim WH. Tumour suppressor gene expression correlates with gastric cancer prognosis. J Pathol 2003, 200(1):39-46. 10.1002/path.1288, 12692839.
27. Lee HS, Lee BL, Kim SH, Woo DK, Kim HS, Kim WH. Microsatellite instability in synchronous gastric carcinomas. Int J Cancer 2001, 91(5):619-624. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1105>3.0.CO;2-P, 11267970.
28. Holmes T, O'Brien TA, Knight R, Lindeman R, Shen S, Song E, Symonds G, Dolnikov A. Glycogen synthase kinase-3β inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth. Stem Cells 2008, 26(5):1288-1297. 10.1634/stemcells.2007-0600, 18323411.
29. Takahashi-Yanaga F, Sasaguri T. GSK-3β regulates cyclin D1 expression: a new target for chemotherapy. Cell Signal 2008, 20(4):581-589. 10.1016/j.cellsig.2007.10.018, 18023328.
30. D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru K, Moon RT, Davis R, Lisanti MP, Shtutman M, Zhurinsky J, Ben-Ze'ev A, Troussard AA, Dedhar S, Pestell RG. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3β and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem 2000, 275(42):32649-32657. 10.1074/jbc.M000643200, 10915780.
31. Gotoh J, Obata M, Yoshie M, Kasai S, Ogawa K. Cyclin D1 over-expression correlates with β-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3β and ERK1/2 in mouse hepatic carcinogenesis. Carcinogenesis 2003, 24(3):435-442. 10.1093/carcin/24.3.435, 12663502.
32. Yang K, Guo Y, Stacey WC, Harwalkar J, Fretthold J, Hitomi M, Stacey DW. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels. BMC Cell Biol 2006, 7:33. 10.1186/1471-2121-7-33, 1592484, 16942622.
33. Pan MH, Chang YH, Badmaev V, Nagabhushanam K, Ho CT. Pterostilbene induces apoptosis and cell cycle arrest in human gastric carcinoma cells. J Agric Food Chem 2007, 55(19):7777-7785. 10.1021/jf071520h, 17696482.